10x Genomics Reports First Quarter 2022 Financial Results

Q1 2022 revenue growth of 8% over prior year PLEASANTON, Calif., May 4, 2022 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG) today reported financial results for the first quarter ended March 31, 2022. Recent Highlights Revenue was $114.5 million for the first quarter, representing an 8%...

Click to view original post